Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden · Delayed Price · Currency is SEK 3.450
-0.080 (-2.27%)
Mar 5, 2026, 9:23 AM CET
Scandinavian ChemoTech AB Market Cap
Scandinavian ChemoTech AB has a market cap or net worth of 89.85 million as of March 4, 2026. Its market cap has increased by 218.10% in one year.
Market Cap
89.85M
Enterprise Value
86.18M
Revenue
12.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.45
Market Cap Chart
Since December 6, 2016, Scandinavian ChemoTech AB's market cap has increased from 63.83M to 89.85M, an increase of 40.77%. That is a compound annual growth rate of 3.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 90.36M | -22.89% |
| Dec 30, 2025 | 117.19M | 180.45% |
| Dec 30, 2024 | 41.79M | -4.97% |
| Dec 29, 2023 | 43.97M | -27.52% |
| Dec 30, 2022 | 60.67M | -63.03% |
| Dec 30, 2021 | 164.08M | 100.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 137.34M |
| IRLAB Therapeutics AB | 131.82M |
| Simris Group AB (PUBL) | 128.23M |
| Xbrane Biopharma AB | 127.86M |
| Biovica International AB | 105.09M |
| Annexin Pharmaceuticals AB | 103.06M |
| Alligator Bioscience AB | 102.73M |
| Biosergen AB | 90.17M |